Interim CFO for AIM listed diagnostics company. Undertaking a
- Strategic review and relaunch of the business following a period
of decline
- Fundraising to support the future business plans during Covid-19
- improved Governance and Compliance
Interim CFO for
Digital Therapeutic company. Supporting the business through its
fundraising and to.
- Refine the business model to achieve profitability on its service
offering
- Develop strategic plans to enable the team to meet its objectives
- Improve the budgetary control in the business to maximise its cash
run
Interim CFO for leading immuno-oncolytic virus
company. Working with a well-established management team too.
- Deliver on transformational
out-licensing deal
- Develop and implement
strategy for the next stage of growth
- Manage expansion into the US with preparation for a US IPO and cross over
fundraising
CFO for global provider of diagnostic products and services
- Successfully acquired and integrated five companies
- Directly responsible for fundraising to support acquisitions and working capital
- Coordinated and directed intensive due diligence processes through acquisition and fundraising activities
- Restructured and refocused business
Finance Director for speciality pharmaceutical plc group with a strong track record of acquiring the rights for prescription products
- Directed complete financial, legal, and operational activities for 12 brand acquisitions funded by a blend of bank debt and equity fundraisings
- Directed flotation on to AIM achieved by reverse takeover of shell-company and subsequent fundraisings
